Clinical trial
Sense to Act: Pilot Randomized-controlled Trial of an Interoceptive Sensibility Intervention for Musculoskeletal Pain
NCT06285864 is registered in ClinicalTrials.gov with Iscte-University Institute of Lisbon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sense to Act: Pilot Randomized-controlled Trial of an Interoceptive Sensibility Intervention for Musculoskeletal Pain
- Lead sponsor
- Iscte-University Institute of Lisbon
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 11, 2024
- Completion date
- June 30, 2024
- Enrollment
- 71 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.